Press Releases

PRESS RELEASE November 26, 2013

Immune Pharmaceuticals’ Common Stock Approved for Trading on NASDAQ OMX First North Premier

 TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Nov. 26, 2013 /PRNewswire/ — Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that its common stock has been approved for trading on NASDAQ OMX First North Premier, Stockholm (“First North”). The Company will transfer its common stock listing from the NASDAQ OMX Stockholm Exchange on November […]

Keep Reading

PRESS RELEASE November 20, 2013

Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results

TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Nov. 20, 2013 /PRNewswire/ — Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) (“Immune” or the “Company”) announced today its financial results for the three and nine month periods ended September 30, 2013.  During the third quarter of 2013, Immune recorded net income attributable to common stockholders of $1.2 […]

Keep Reading

PRESS RELEASE November 1, 2013

Immune Pharmaceuticals Appoints Liquidity Provider to Facilitate Trading on NASDAQ OMX Stockholm Exchange

TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Nov. 1, 2013 /PRNewswire/ — Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that it has appointed Erik Penser Bankaktiebolag as a liquidity provider  for the Company’s common shares currently listed on NASDAQ OMX Stockholm Exchange  under the trading symbol IMNP. The firm will continue to be […]

Keep Reading

PRESS RELEASE October 16, 2013

New Data Supports Clinical Rationale for Bertilimumab in Ulcerative Colitis

TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Oct. 16, 2013 /PRNewswire/ — Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that Tomer Adar, M.D. at the Digestive Diseases Institute, Shaare Zedek Medical Center, Hebrew University of Jerusalem, presented a poster on October 15, 2013 entitled Inhibition of Eotaxin-1 (CCL 11) Ameliorates DSS-Induced Colitis; A […]

Keep Reading

PRESS RELEASE October 15, 2013

Immune Pharmaceuticals Announces Changes to its Board of Directors

TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Oct. 15, 2013 /PRNewswire/ — Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP), announced today that Rene Lerer, M.D., Executive Chairman of Magellan Health Services (NASDAQ: MGLN), and Daniel Kazado, Senior Advisor to Melini Capital, have agreed to join the Company’s Board of Directors. Dr. Lerer and Mr. […]

Keep Reading

PRESS RELEASE October 3, 2013

IMMUNE Pharmaceuticals Inc. to Present at 12th Annual BIO Investor Forum

TARRYTOWN, N.Y., Oct. 3, 2013 /PRNewswire/ — Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that Dr. Daniel G. Teper, Company Chairman and CEO, will be presenting at the 12th Annual BIO Investor Forum. Hosted by the Biotechnology Industry Organization (BIO), the 12th Annual BIO Investor Forum features leading private and emerging […]

Keep Reading

PRESS RELEASE September 30, 2013

Immune Pharmaceuticals Announces Focus on Capital Raising and Primary Listing in The United States

TARRYTOWN, N.Y., Sept. 30, 2013 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ OMX Stockholm Exchange and OTCQX: IMNP) (“IMMUNE” or the “Company”) announced today that following the recent merger of Immune Pharmaceuticals Ltd. and EpiCept Corporation, the Company will focus its capital raising efforts in the United States to support its objective to up-list to a U.S. […]

Keep Reading

PRESS RELEASE September 23, 2013

Immune Pharmaceuticals Inc. Trading Symbol is Now IMNP on Both NASDAQ OMX Stockholm Exchange and OTCQX Trading Platform

TARRYTOWN, N.Y., Sept. 23, 2013 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ OMX Stockholm Exchange: IMNP and OTCQX: IMNP, formerly EPCTD) announced today that effective September 23, 2013 the Company’s symbol for its common stock trading on the OTCQX trading platform will change to “IMNP”. The Company’s common stock had been required to trade under the symbol […]

Keep Reading